BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12533840)

  • 1. NEDD8 protein is involved in ubiquitinated inclusion bodies.
    Dil Kuazi A; Kito K; Abe Y; Shin RW; Kamitani T; Ueda N
    J Pathol; 2003 Feb; 199(2):259-66. PubMed ID: 12533840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
    Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease.
    Lowe J; McDermott H; Pike I; Spendlove I; Landon M; Mayer RJ
    J Pathol; 1992 Jan; 166(1):61-8. PubMed ID: 1311375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease.
    Lowe J; Blanchard A; Morrell K; Lennox G; Reynolds L; Billett M; Landon M; Mayer RJ
    J Pathol; 1988 May; 155(1):9-15. PubMed ID: 2837558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of protein ubiquitination in neurodegenerative disease.
    Mayer RJ; Lowe J; Landon M; McDermott H; László L
    Acta Biol Hung; 1991; 42(1-3):21-6. PubMed ID: 1668896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
    Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
    Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM; van Leeuwen FW; Fischer DF
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases.
    Mayer RJ; Lowe J; Lennox G; Doherty F; Landon M
    Prog Clin Biol Res; 1989; 317():809-18. PubMed ID: 2557642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HSP 70 is associated with abnormal cytoplasmic inclusions characteristic of neurodegenerative diseases].
    Namba Y; Tomonaga M; Ohtsuka K; Oda M; Ikeda K
    No To Shinkei; 1991 Jan; 43(1):57-60. PubMed ID: 2054224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of ubiquitin immunohistochemistry to the diagnosis of disease.
    Lowe J; Hand N; Mayer RJ
    Methods Enzymol; 2005; 399():86-119. PubMed ID: 16338351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent modification of all members of human cullin family proteins by NEDD8.
    Hori T; Osaka F; Chiba T; Miyamoto C; Okabayashi K; Shimbara N; Kato S; Tanaka K
    Oncogene; 1999 Nov; 18(48):6829-34. PubMed ID: 10597293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ubiquitin and degenerative diseases of the central nervous system].
    Tranchant C; Muller S; Warter JM
    Rev Neurol (Paris); 1992; 148(12):731-5. PubMed ID: 1338933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate filament-ubiquitin diseases: implications for cell sanitization.
    Mayer RJ; Lowe J; Lennox G; Landon M; MacLennan K; Doherty FJ
    Biochem Soc Symp; 1989; 55():193-201. PubMed ID: 2559734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel substrates and functions for the ubiquitin-like molecule NEDD8.
    Xirodimas DP
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):802-6. PubMed ID: 18793140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteomic approach to assess intraneuronal inclusions associated with neurodegenerative disorders.
    Kawaja MD
    Curr Opin Mol Ther; 2005 Dec; 7(6):565-8. PubMed ID: 16370379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin: a multifunctional regulatory protein associated with the cytoskeleton.
    Fried VA; Smith HT
    Prog Clin Biol Res; 1989; 317():733-44. PubMed ID: 2557641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin.
    Chang HT; Cortez S; Vonsattel JP; Stopa EG; Schelper RL
    Acta Neuropathol; 2004 Jul; 108(1):10-6. PubMed ID: 15108011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.